The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

Therapeutic Advances in Cardiovascular Disease

Volumn 10, Issue 5, 2016, Pages 282-293

  Saleh, Langeza ^a   Verdonk, Koen ^a   Visser, Willy ^a   Van Den Meiracker, Anton H ^a   Danser, A H Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

angiotensin; auto antibody; cancer; endothelial growth factor; endothelin 1; nitric oxide; pre eclampsia; soluble Fms like tyrosine kinase 1; vascular endothelial growth factor

Indexed keywords

ALDOSTERONE; AMBRISENTAN; ATRASENTAN; BOSENTAN; CALCIUM ANTAGONIST; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MACITENTAN; SUNITINIB; VASCULOTROPIN; ANGIOTENSIN 1 RECEPTOR; ENDOTHELIN RECEPTOR;

CANCER PATIENT; CLINICAL FEATURE; HEART OUTPUT; HUMAN; HYPERTENSION; HYPOVOLEMIA; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEINURIA; PULMONARY HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCTION; REVIEW; SYSTEMIC VASCULAR RESISTANCE; VASCULAR DISEASE; ANIMAL; FEMALE; HEMODYNAMICS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY;

ANIMALS; ENDOTHELIN-1; FEMALE; HEMODYNAMICS; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ENDOTHELIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84984687968     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944715624853     Document Type: Review

References (117)

1. Aggarwal P., Chandel N., Jain V., Jha V., (2012) The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in pre-eclampsia. J Hum Hypertens 26: 236-241.
2. Alexander B., Kassab S., Miller M., Abram S., Reckelhoff J., Bennett W., et al. (2001a) Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 37: 1191-1195.
3. Alexander B., Rinewalt A., Cockrell K., Massey M., Bennett W., Granger J., (2001b) Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 37: 485-489.
4. Aydin S., Benian A., Madazli R., Uludag S., Uzun H., Kaya S., (2004) Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 113: 21-25.
5. Baker P., Kilby M., Broughton Pipkin F., (1992) The effect of angiotensin II on platelet intracellular free calcium concentration in human pregnancy. J Hypertens 10: 55-60.
6. Baksu B., Davas I., Baksu A., Akyol A., Gulbaba G., (2005) Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women. Int J Gynecol Obstet 90: 112-117.
7. Bédard E., Dimopoulos K., Gatzoulis M., (2009) Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 30: 256-265.
8. Bernardi F., Constantino L., Machado R., Petronilho F., Dal-Pizzol F., (2008) Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women. J Obstet Gynaecol Res 34: 957-963.
9. Boulanger C., Lüscher T., (1990) Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85: 587-590.
10. Brosens I., (1964) A Study of the spiral arteries of the decidua basalis in normotensive and hypertensive pregnancies. J Obstet Gynaecol Br Commonw 71: 222-230.
11. Brunner F., Stessel H., Kukovetz W., (1995) Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett 376: 262-266.
12. Bussen S., Sutterlin M., Steck T., (1999) Plasma endothelin and big endothelin levels in women with severe pre-eclampsia or HELLP syndrome. Arch Gynecol Obstet 262: 113-119.
13. Clouthier D., Hosoda K., Richardson J., Williams S., Yanagisawa H., Kuwaki T., et al. (1998) Cranial and cardiac neural crest defects in endothelin-A-receptor-deficient mice. Development 125: 813-824.
14. Danser A., Derkx F., Schalekamp M., Hense H., Riegger G., Schunkert H., (1998) Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 16: 853-862.
15. Dohi Y., Hahn A., Boulanger C., Buhler F., Lüscher T., (1992) Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 19: 131-137.
16. D'orleans-Juste P., Labonte J., Bkaily G., Choufani S., Plante M., Honore J., (2002) Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther 95: 221-238.
17. Dupuis J., Stewart D., Cernacek P., Gosselin G., (1996) Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 94: 1578-1584.
18. Ekelund U., Adner M., Edvinsson L., Mellander S., (1994) Effects of selective ETB-receptor stimulation on arterial, venous and capillary functions in cat skeletal muscle. Br J Pharmacol 112: 887-894.
19. Faas M., Schuiling G., Baller J., Visscher C., Bakker W., (1994) A new animal model for human pre-eclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 171: 158-164.
20. Facchinetti F., Longo M., Piccinini F., Neri I., Volpe A., (1999) L-arginine infusion reduces blood pressure in pre-eclamptic women through nitric oxide release. J Soc Gynecol Investig 6: 202-207.
21. Faxen M., Nasiell J., Lunell N., Blanck A., (1997) Differences in mRNA expression of endothelin-1, c-fos and c-jun in placentas from normal pregnancies and pregnancies complicated with pre-eclampsia and/or intrauterine growth retardation. Gynecol Obstet Invest 44: 93-96.
22. Fiore G., Florio P., Micheli L., Nencini C., Rossi M., Cerretani D., et al. (2005) Endothelin-1 triggers placental oxidative stress pathways: putative role in pre-eclampsia. J Clin Endocrinol Metab 90: 4205-4210.
23. B in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol 44: S362-S365.
24. Frank H., Levin E., Hu R., Pedram A., (1993) Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology 133: 1092-1097.
25. Friedman S., Schiff E., Lubarsky S., Sibai B., (1999) Expectant management of severe pre-eclampsia remote from term. Clin Obstet Gynecol 42: 470-478.
26. Fukuchi M., Giaid A., (1998) Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts. J Cardiovasc Pharmacol 31: S421-S423.
27. B receptors in rats. Biochem Biophys Res Commun 199: 1461-1465.
28. Fukuroda T., Ozaki S., Ihara M., Ishikawa K., Yano M., Miyauchi T., et al. (1996) Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi. Br J Pharmacol 117: 995-999.
29. Gandhi C., Harvey S., Olson M., (1993) Hepatic effects of endothelin: metabolism of [125I]endothelin-1 by liver-derived cells. Arch Biochem Biophys 305: 38-46.
30. Gant N., Daley G., Chand S., Whalley P., Macdonald P., (1973) A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 52: 2682-2689.
31. Gariepy C., Ohuchi T., Williams S., Richardson J., Yanagisawa M., (2000) Salt-sensitive hypertension in endothelin-B-receptor-deficient rats. J Clin Invest 105: 925-933.
32. Gennari-Moser K., Escher G., Burkhard F., Frey B., Karumanchi S., Frey F., et al. (2013) Vascular endothelial growth-factor A and aldosterone: relevance to normal pregnancy and pre-eclampsia. Hypertension 61: 1111-1117.
33. Granger J., Alexander B., Llinas M., Bennett W., Khalil R., (2002) Pathophysiology of pre-eclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9: 147-160.
34. Hall M., George E., Granger J., (2011) The heart during pregnancy. Rev Esp Cardiol 64: 1045-1050.
35. Haram K., Svendsen E., Abildgaard U., (2009) The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth 9: 8.
36. Hayman S., Leung N., Grande J., Garovic V., (2012) VEGF inhibition, hypertension and renal toxicity. Curr Oncol Rep 14: 285-294.
37. Herse F., Dechend R., Harsem N., Wallukat G., Janke J., Qadri F., et al. (2007) Dysregulation of the circulating and tissue-based renin-angiotensin system in pre-eclampsia. Hypertension 49: 604-611.
38. Hilal-Dandan R., Ramirez M., Villegas S., Gonzalez A., Endo-Mochizuki Y., Brown J., et al. (1997) Endothelin ETA receptor regulates signaling and ANF gene expression via multiple G protein-linked pathways. Am J Physiol 272: H130-H137.
39. Humbert M., Sitbon O., Simonneau G., (2004) Treatment of pulmonary arterial hypertension. N Engl J Med 351: 1425-1436.
40. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., et al. (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863-2867.
41. Jougasaki M., Larsen A., Cataliotti A., Christiansen D., Burnett J. Jr., (2002) Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells. Peptides 23: 1441-1447.
42. Kappers M., Smedts F., Horn T., Van Esch J., Sleijfer S., Leijten F., et al. (2011) The vascular endothelial growth factor receptor inhibitor sunitinib causes a pre-eclampsia-like syndrome with activation of the endothelin system. Hypertension 58: 295-302.
43. Kappers M., Van Esch J., Sluiter W., Sleijfer S., Danser A., Van Den Meiracker A., (2010) Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels. Hypertension 56: 675-681.
44. Karakus S., Bozoklu Akkar O., Yildiz C., Sancakdar E., Cetin M., Cetin A., (in press) Serum levels of ET-1, M30 and angiopoietins-1 and -2 in HELLP syndrome and pre-eclampsia compared to controls. Arch Gynecol Obstet.
45. Khimji A., Rockey D., (2010) Endothelin-biology and disease. Cell Signal 22: 1615-1625.
46. Kiprono L., Wallace K., Moseley J., Martin Jr, J., LaMarca B., (2013) Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia. Am J Obstet Gynecol 209: 44e41-44e46.
47. Kohan D., (1997) Endothelins in the normal and diseased kidney. Am J Kidney Dis 29: 2-26.
48. Kurihara Y., Kurihara H., Suzuki H., Kodama T., Maemura K., Nagai R., et al. (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710.
49. LaMarca B., Parrish M., Ray L., Murphy S., Roberts L., Glover P., et al. (2009) Hypertension in response to auto-antibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 54: 905-909.
50. Lankhorst S., Baelde H., Kappers M., Smedts F., Hansen A., Clahsen-Van Groningen M., et al. (2015) Greater sensitivity of blood pressure than renal toxicity to tyrosine kinase receptor inhibition with sunitinib. Hypertension 66: 543-549.
51. Lankhorst S., Kappers M., Van Esch J., Danser A., Van Den Meiracker A., (2013) Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1. J Hypertens 31: 444-454.
52. Lankhorst S., Kappers M., Van Esch J., Smedts F., Sleijfer S., Mathijssen R., et al. (2014) Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study. Hypertension 64: 1282-1289.
53. Levin E., (1995) Endothelins. N Engl J Med 333: 356-363.
54. MacCumber M., Ross C., Glaser B., Snyder S., (1989) Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A 86: 7285-7289.
55. MacCumber M., Ross C., Snyder S., (1990) Endothelin in brain: receptors, mitogenesis and biosynthesis in glial cells. Proc Natl Acad Sci U S A 87: 2359-2363.
56. Maguire J., Johnson C., Mockridge J., Davenport A., (1997) Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol 122: 1647-1654.
57. Makris A., Thornton C., Thompson J., Thomson S., Martin R., Ogle R., et al. (2007) Uteroplacental ischemia results in proteinuric hypertension and elevated sFlt-1. Kidney Int 71: 977-984.
58. Malassine A., Cronier L., Mondon F., Mignot T., Ferre F., (1993) Localization and production of immunoreactive endothelin-1 in the trophoblast of human placenta. Cell Tissue Res 271: 491-497.
59. Marasciulo F., Montagnani M., Potenza M., (2006) Endothelin-1: the yin and yang on vascular function. Curr Med Chem 13: 1655-1665.
60. Masaki T., (2004) Historical review: endothelin. Trends Pharmacol Sci 25: 219-224.
61. Masaki T., Yanagisawa M., Goto K., (1992) Physiology and pharmacology of endothelins. Med Res Rev 12: 391-421.
62. Maynard S., Epstein F., Karumanchi S., (2008) Pre-eclampsia and angiogenic imbalance. Annu Rev Med 59: 61-78.
63. Maynard S., Min J., Merchan J., Lim K., Li J., Mondal S., et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension and proteinuria in pre-eclampsia. J Clin Invest 111: 649-658.
64. Mazzuca M., Li W., Reslan O., Yu P., Mata K., Khalil R., (2014) Downregulation of microvascular endothelial type B endothelin receptor is a central vascular mechanism in hypertensive pregnancy. Hypertension 64: 632-643.
65. McMahon L., Redman C., Firth J., (1993) Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations. Clin Sci (Lond) 85: 417-424.
66. Moltzer E., Verkuil A., Van Veghel R., Danser A., Van Esch J., (2010) Effects of angiotensin metabolites in the coronary vascular bed of the spontaneously hypertensive rat: loss of angiotensin II type 2 receptor-mediated vasodilation. Hypertension 55: 516-522.
67. Motte S., Mcentee K., Naeije R., (2006) Endothelin receptor antagonists. Pharmacol Ther 110: 386-414.
68. Murphy S., LaMarca B., Cockrell K., Arany M., Granger J., (2012) L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats. Am J Physiol Regul Integr Comp Physiol 302: R259-R263.
69. Murphy S., LaMarca B., Cockrell K., Granger J., (2010) Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 55: 394-398.
70. Myatt L., (2002) Role of placenta in pre-eclampsia. Endocrine 19: 103-111.
71. Naljayan M., Karumanchi S., (2013) New developments in the pathogenesis of pre-eclampsia. Adv Chronic Kidney Dis 20: 265-270.
72. Napolitano M., Miceli F., Calce A., Vacca A., Gulino A., Apa R., et al. (2000) Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and pre-eclamptic placentas. J Clin Endocrinol Metab 85: 2318-2323.
73. Nova A., Sibai B., Barton J., Mercer B., Mitchell M., (1991) Maternal plasma level of endothelin is increased in pre-eclampsia. Am J Obstet Gynecol 165: 724-727.
74. Ohkita M., Takaoka M., Shiota Y., Nojiri R., Matsumura Y., (2002) Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin Sci (Lond) 103: 68S-71S.
75. A-receptor antagonist HJP272, a 1,3,6-trisubstituted-2-carboxy-quinol-4-one, on infection-mediated premature delivery. Can J Physiol Pharmacol 86: 571-575.
76. Ortiz-Capisano M., (2014) Endothelin inhibits renin release from juxtaglomerular cells via endothelin receptors A and B via a transient receptor potential canonical-mediated pathway. Physiol Rep 12: e12240.
77. A receptor activation. Am J Physiol 264: R222-R226.
78. Powe C., Levine R., Karumanchi S., (2011) Pre-eclampsia, a disease of the maternal endothelium: the role of anti-angiogenic factors and implications for later cardiovascular disease. Circulation 123: 2856-2869.
79. A receptors. Hypertension 66: 347-355.
80. Redman C., (1992) Immunological aspects of pre-eclampsia. Baillieres Clin Obstet Gynaecol 6: 601-615.
81. Redman C., Sargent I., (2005) Latest advances in understanding pre-eclampsia. Science 308: 1592-1594.
82. Reichetzeder C., Tsuprykov O., Hocher B., (2014) Endothelin receptor antagonists in clinical research: lessons learned from preclinical and clinical kidney studies. Life Sci 118: 141-148.
83. Ritthaler T., Scholz H., Ackermann M., Riegger G., Kurtz A., Bk K., (1995) Effects of endothelins on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol 268: F39-F45.
84. Roberts J., Redman C., (1993) Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 341: 1447-1451.
85. Romani De Wit T., Rondaij M., Van Mourik J., (2004) Weibel-Palade bodies: unique secretory organelles within endothelial cells. Ned Tijdschr Geneeskd 148: 1572-1577.
86. Rubanyi G., Polokoff M., (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 46: 325-415.
87. Rytlewski K., Olszanecki R., Korbut R., Zdebski Z., (2005) Effects of prolonged oral supplementation with L-arginine on blood pressure and nitric oxide synthesis in pre-eclampsia. Eur J Clin Invest 35: 32-37.
88. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., et al. (1990) Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735.
89. Seki H., (2014) Balance of anti-angiogenic and angiogenic factors in the context of the etiology of pre-eclampsia. Acta Obstet Gynecol Scand 93: 959-964.
90. B receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan. Hypertension 25: 501-506.
91. Smith P., Teichert-Kuliszewska K., Monge J., Stewart D., (1998) Regulation of endothelin-B receptor mRNA expression in human endothelial cells by cytokines and growth factors. J Cardiovasc Pharmacol 31: S158-S160.
92. Staff A., Berge L., Haugen G., Lorentzen B., Mikkelsen B., Henriksen T., (2004) Dietary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 83: 103-107.
93. Steegers E., Von Dadelszen P., Duvekot J., Pijnenborg R., (2010) Pre-eclampsia. Lancet 376: 631-644.
94. Takahashi M., Matsushita Y., Iijima Y., Tanzawa K., (1993) Purification and characterization of endothelin-converting enzyme from rat lung. J Biol Chem 268: 21394-21398.
95. Taniguchi T., Muramatsu I., (2003) Pharmacological knockout of endothelin ET(A) receptors. Life Sci 74: 405-409.
96. Taylor R., Varma M., Teng N., Roberts J., (1990) Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 71: 1675-1677.
97. Thadhani R., Kisner T., Hagmann H., Bossung V., Noack S., Schaarschmidt W., et al. (2011) Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in pre-eclampsia. Circulation 124: 940-950.
98. Thaete L., Neerhof M., Silver R., (2001) Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats. J Soc Gynecol Investig 8: 18-23.
99. Treinen K., Louden C., Dennis M., Wier P., (1999) Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits. Teratology 59: 51-59.
100. Van Mourik J., Romani De Wit T., Voorberg J., (2002) Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 117: 113-122.
101. Verdonk K., Saleh L., Lankhorst S., Smilde J., Van Ingen M., Garrelds I., et al. (2015) Association studies suggest a key role for endothelin-1 in the pathogenesis of pre-eclampsia and the accompanying renin-angiotensin-aldosterone system suppression. Hypertension 65: 1316-1323.
102. Verdonk K., Visser W., Van Den Meiracker A., Danser A., (2014) The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad. Clin Sci (Lond) 126: 537-544.
103. Vierhapper H., Wagner O., Nowotny P., Waldhausl W., (1990) Effect of endothelin-1 in man. Circulation 81: 1415-1418.
104. Von Dadelszen P., Magee L., Roberts J., (2003) Subclassification of pre-eclampsia. Hypertens Pregnancy 22: 143-148.
105. Wagner O., Christ G., Wojta J., Vierhapper H., Parzer S., Nowotny P., et al. (1992) Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066-16068.
106. Walther T., Wallukat G., Jank A., Bartel S., Schultheiss H., Faber R., et al. (2005) Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 46: 1275-1279.
107. Watanabe H., Miyazaki H., Kondoh M., Masuda Y., Kimura S., Yanagisawa M., et al. (1989) Two distinct types of endothelin receptors are present on chick cardiac membranes. Biochem Biophys Res Commun 161: 1252-1259.
108. Weitzberg E., Ahlborg G., Lundberg J., (1991) Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues. Biochem Biophys Res Commun 180: 1298-1303.
109. Wenzel K., Rajakumar A., Haase H., Geusens N., Hubner N., Schulz H., et al. (2011) Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension 58: 77-84.
110. Wolff K., Nisell H., Carlstrom K., Kublickiene K., Hemsen A., Lunell N., et al. (1996) Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in pre-eclampsia. Regul Pept 67: 211-216.
111. Xu D., Emoto N., Giaid A., Slaughter C., Kaw S., Dewit D., et al. (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473-485.
112. Yanagisawa H., Hammer R., Richardson J., Williams S., Clouthier D., Yanagisawa M., (1998a) Role of Endothelin-1/Endothelin-A-receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest 102: 22-33.
113. Yanagisawa H., Yanagisawa M., Kapur R., Richardson J., Williams S., Clouthier D., et al. (1998b) Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125: 825-836.
114. Yanagisawa M., (1994) The endothelin system. A new target for therapeutic intervention. Circulation 89: 1320-1322.
115. Zenclussen A., Fest S., Joachim R., Klapp B., Arck P., (2004) Introducing a mouse model for pre-eclampsia: adoptive transfer of activated Th 1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant mice. Eur J Immunol 34: 377-387.
116. Zhou C., Irani R., Dai Y., Blackwell S., Hicks M., Ramin S., et al. (2011) Auto-antibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of pre-eclampsia. J Immunol 186: 6024-6034.
117. Zhou C., Zhang Y., Irani R., Zhang H., Mi T., Popek E., et al. (2008) Angiotensin receptor agonistic auto-antibodies induce pre-eclampsia in pregnant mice. Nat Med 14: 855-862.